首页> 外文期刊>Thoracic cancer. >Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non‐small cell lung cancer
【24h】

Effect of visceral pleural invasion on the prognosis of patients with lymph node negative non‐small cell lung cancer

机译:内脏胸膜浸润对淋巴结阴性非小细胞肺癌患者预后的影响

获取原文
获取外文期刊封面目录资料

摘要

Abstract BackgroundVisceral pleural invasion (VPI) is an adverse prognostic factor in non-small cell lung cancer (NSCLC); however, its effect in relation to tumor size remains under debate. To better understand the prognostic impact and potential consequences for staging, we examined correlations between VPI and clinicopathologic characteristics in patients with NSCLC, particularly those with lymph node negative NSCLC. MethodsWe retrospectively analyzed 813 cases of radically resected NSCLC treated in our institution between December 2005 and December 2011. Patients were divided into two groups according to VPI status to compare their clinicopathologic characteristics. Survival analysis was performed in 521 cases with pN0 NSCLC. Results VPI was diagnosed in 379 (46.6%) cases. It was more common in women, patients with non-squamous cell carcinoma, elevated preoperative serum carcinoembryonic antigen levels, moderately or poorly differentiated tumors, and larger-sized tumors. The incidence of mediastinal lymph node metastasis, particularly multi-station metastasis, was higher in patients with VPI. Patients with pN0 NSCLC, 2–3?cm tumors, and VPI had a significantly poorer prognosis (VPI vs. non-VPI: five-year overall survival 78.3% vs. 84.5%, P =?0.039; five-year disease-free survival 69.2% vs. 80.0%, P =?0.046, respectively); however, no significant effect was observed for tumors ≤2, 3–5, and 5–7?cm. P-N0 patients with VPI had a significantly higher incidence of postoperative local recurrence and distant metastasis than those without VPI ( P =?0.01), especially ipsilateral pleural recurrence. Conclusion VPI was an adverse prognostic factor in radically resected pN0 NSCLC, especially for tumors 2–3?cm in size.
机译:摘要背景内脏胸膜侵犯(VPI)是非小细胞肺癌(NSCLC)的不良预后因素。然而,其与肿瘤大小有关的作用仍在争论中。为了更好地了解分期的预后影响和潜在后果,我们检查了NSCLC患者(尤其是淋巴结阴性NSCLC患者)的VPI与临床病理特征之间的相关性。方法回顾性分析我院2005年12月至2011年12月收治的813例根治性NSCLC患者的临床资料。根据VPI状况将患者分为两组,比较其临床病理特征。对521例pN0 NSCLC患者进行了生存分析。结果VPI被诊断为379例(46.6%)。它在女性,非鳞状细胞癌,术前血清癌胚抗原水平升高,中度或低度分化的肿瘤以及较大尺寸的肿瘤中更为常见。 VPI患者的纵隔淋巴结转移,尤其是多站转移的发生率较高。 pN0 NSCLC,2-3 cm肿瘤和VPI的患者预后明显较差(VPI与非VPI:五年总生存期78.3%vs. 84.5%,P =?0.039;五年无病生存率分别为69.2%和80.0%,P =?0.046);然而,对于≤2、3–5和5–7?cm的肿瘤,未观察到显着影响。 P-N0伴VPI的患者术后局部复发和远处转移的发生率显着高于无VPI的患者(P =?0.01),尤其是同侧胸膜复发。结论VPI是彻底切除pN0 NSCLC的不良预后因素,尤其是对于2–3?cm大小的肿瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号